n-3 PUFA: bioavailability and modulation of adipose tissue function
- 24 August 2009
- journal article
- review article
- Published by Cambridge University Press (CUP) in Proceedings of the Nutrition Society
- Vol. 68 (4), 361-369
- https://doi.org/10.1017/s0029665109990231
Abstract
Adipose tissue has a key role in the development of metabolic syndrome (MS), which includes obesity, type 2 diabetes, dyslipidaemia, hypertension and other disorders. Systemic insulin resistance represents a major factor contributing to the development of MS in obesity. The resistance is precipitated by impaired adipose tissue glucose and lipid metabolism, linked to a low-grade inflammation of adipose tissue and secretion of pro-inflammatory adipokines. Development of MS could be delayed by lifestyle modifications, while both dietary and pharmacological interventions are required for the successful therapy of MS. The n-3 long-chain (LC) PUFA, EPA and DHA, which are abundant in marine fish, act as hypolipidaemic factors, reduce cardiac events and decrease the progression of atherosclerosis. Thus, n-3 LC PUFA represent healthy constituents of diets for patients with MS. In rodents n-3 LC PUFA prevent the development of obesity and impaired glucose tolerance. The effects of n-3 LC PUFA are mediated transcriptionally by AMP-activated protein kinase and by other mechanisms. n-3 LC PUFA activate a metabolic switch toward lipid catabolism and suppression of lipogenesis, i.e. in the liver, adipose tissue and small intestine. This metabolic switch improves dyslipidaemia and reduces ectopic deposition of lipids, resulting in improved insulin signalling. Despite a relatively low accumulation of n-3 LC PUFA in adipose tissue lipids, adipose tissue is specifically linked to the beneficial effects of n-3 LC PUFA, as indicated by (1) the prevention of adipose tissue hyperplasia and hypertrophy, (2) the induction of mitochondrial biogenesis in adipocytes, (3) the induction of adiponectin and (4) the amelioration of adipose tissue inflammation by n-3 LC PUFA.Keywords
This publication has 75 references indexed in Scilit:
- Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese MiceDiabetes, 2009
- Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectinsThe FASEB Journal, 2009
- Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat dietBMC Genomics, 2009
- Phenotypic Switching of Adipose Tissue Macrophages With Obesity Is Generated by Spatiotemporal Differences in Macrophage SubtypesDiabetes, 2008
- Effect of Synthetic Dietary Triglycerides: A Novel Research Paradigm for NutrigenomicsPLOS ONE, 2008
- Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitusDiabetologia, 2007
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1cBiochemical Journal, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Dietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in ratsBiochemical and Biophysical Research Communications, 2005